Pro-dex, Inc. · NASDAQ:PDEX

Pro-dex — Investor Presentation (June 2026)

12 slides from Pro-dex's investor presentation, Jun 16, 2026

  1. Slide 1: Investor Presentation

    Investor Presentation Presented by Rick Van Kirk (CEO and BOD Member) Angel Domingo (Sen. Dir. of QA/RA and BOD Member)

  2. Slide 2: Disclaimer

    Disclaimer Safe Harbor Statement Statements made during Pro-Dex’s presentation and its representative’s answers to questions that refer to Pro- Dex’s estimated or anticipated future results or other non-public historical facts are forward-looking statements, as are any statements its representatives

  3. Slide 3: Investment Highlights

    Investment Highlights A Platform Built for Sustainable Growth Pro-Dex is a High-Growth Innovative Finished Device Contract Manufacturer Strong Long-Term High-Value Proprietary Stable Core Proven Management Partnerships with Leading Product Pipeline IP Portfolio Cash Flow Team with Strong Orthopedic

  4. Slide 4: Pro-Dex Past to Present

    Pro-Dex Past to Present A Track Record of Consistent Value Creation PDEX Share Price TTM Earnings Per Share Quarterly1 $80 June 1, 2026 Q3 2026 $4 $3.59 $70 $66.93 $60 $3 $50 $40 $2 $30 $20 $1 $0.52 $6.80 $10 $0 $0 2018 2019 2020 2021 2022 2023 2024 2025 2026 2018 2019 2020 2021 2022 2023 2024 2025

  5. Slide 5: Capabilities & Facilities

    Capabilities & Facilities Full-Scale Precision Manufacturing Infrastructure Pro-Dex’s Capabilities Engineering Regulatory Manufacturing Quality Systems → Full Design from Sketch → 510(k) Submission (US and OUS) → Finished Devices → Master Validation Plan → Reliability Improvement → Sterilization, Sa

  6. Slide 6: Pro-Dex Core Business

    Pro-Dex Core Business Trusted by Global Surgical Leaders → Arthroscopic Shavers → Craniomaxillofacial Drivers Pro-Dex has deployed smart drivers in CMF with 4 major → Thoracic Drivers companies that account for “The interface between → Multifunction Handpieces over 60% of the CMF market surgeons and

  7. Slide 7: Surgical Power: Addressable Market $2-3B

    Surgical Power: Addressable Market $2-3B Strong Market Presence in the CMF Market → Pro-Dex has greater than 50% market share in CMF, the smallest market in the orthopedic space → Opportunity to take share with differentiated solutions in strategic markets (see TorqueDrive) CMF Pro-Dex Focus to Grow

  8. Slide 8: Adaptive Torque Limiting

    Adaptive Torque Limiting Proprietary IP Catalyzes Defensible Competitive Advantage The software algorithm can be integrated across a family of products from small bone and CMF (Helios) to large bone and trauma (Atlas) High product differentiation and a significant driver of sales conversions Our alg

  9. Slide 9: CMF and Thoracic Markets

    CMF and Thoracic Markets Trusted by Surgeons. Backed by Market Leadership Key Capabilities: → Adaptive torque limiting for rapid-driving screws and perfect seating of screws Positive surgeon feedback → Screw stripping prevention → Drill and drive mode capabilities → High precision discrete torque li

  10. Slide 10: High Potential Future Product & Portfolio Growth

    High Potential Future Product & Portfolio Growth Purpose-Built Solutions Across High-Growth Surgical Specialties Helios Pro Driver Articulating Spinal Drill/Driver Arthroscopic Attachment Shaver System → Pro-Dex’s first proprietary → Multi-angle articulation for → Battery-powered driver → Precision-

  11. Slide 11: Management Team

    Management Team Experienced Leadership Committed to Execution and Growth RV AD AC DR Rick Van Kirk Angel Domingo Alisha Charlton Danielle Richterkessing President & CEO1 Senior Director of QA/RA1 CFO Director of Engineering 44+ yrs experience 31+ yrs experience 35+ yrs experience 18+ yrs experience

  12. Slide 12: Pro-DEX

    Pro-DEX POWERFUL SOLUTIONS

Pro-Dex — Investor Presentation (June 2026) on 6ix